clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Molecular Dx
Some Men with Prostate Cancer Can Benefit from Immunotherapy
News & Features
Brain Metastases of HER2-Positive Breast Cancer Patients Effectively Treated with Antibody-Drug…
News & Features
HRT Reduces Insulin Resistance after Menopause According to Meta-Analysis
News & Features
Study Identifies Key Factors for Long-Term Weight Loss with GLP-1 Medications
Coronavirus
AI Effectively Allocates Resources in Pandemic
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
New Research Identifies METRNL Protein as Key Obstacle to Cancer-Fighting T Cells
Bladder cancer
News & Features
New Research Identifies METRNL Protein as Key Obstacle to Cancer-Fighting T Cells
Alisa Kirkin
-
August 7, 2024
0
News & Features
Sequencing Rates Unacceptably Low in Metastatic Prostate and Urothelial Cancers
Laura Cowen
-
July 24, 2024
0
News & Features
IDEAYA’s MAT2A Inhibitor Scores in Phase II for Urothelial and NSCLC
Malorye Branca
-
July 11, 2024
0
News & Features
Liquid Biopsy Shows Which Bladder Cancer Patients Won’t Relapse
Chris Anderson
-
April 5, 2024
0
News & Features
Next-Generation T Cell Therapy Shows Promise For Solid Tumors
Laura Cowen
-
April 3, 2024
0
News & Features
Combo Therapy Approved for HER2-Positive Breast Cancer Effective against Other Cancer Types
Chris Anderson
-
March 4, 2024
0
News & Features
Researchers Learn Why Cisplatin-Based Chemotherapy Works Best in Advanced Bladder Cancer
Chris Anderson
-
January 31, 2024
0
News & Features
Bladder Tumor Size Reduced by 90% in Mouse Model by Self-Propelling Nanobots
Sophia Ktori
-
January 17, 2024
0
News & Features
Veracyte Adds AI-Driven MRD Testing Capabilities with C2i Genomics Acquisition
Chris Anderson
-
January 10, 2024
0
News & Features
Immunotherapy Added to Chemotherapy Nearly Doubles Advanced Bladder Cancer Survival
Malorye Branca
-
October 25, 2023
0
1
2
3
4
Page 1 of 4
Related Content
Some Men with Prostate Cancer Can Benefit from Immunotherapy
New Therapy Shows Promise in Targeting Tau Tangles in Alzheimer’s Disease
Antibiotic Use Linked to Increased Risk of Inflammatory Bowel Disease
New AI Model Enhances Cancer Diagnostics through Virtual Staining
Inside Precision Medicine
